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Abstract
There is a growing body of evidence that epigenetic alterations are involved in the pathological mechanisms of many
chronic disorders linked to fetal programming. Angiotensin-converting enzyme (ACE) appears as one candidate gene that
brings new insights into the epigenetic control and later development of diseases. In this view, we have postulated that
epigenetic modifications in the ACE gene might show different interactions between birth weight (BW), blood pressure
levels, plasma ACE activity and ACE I/D polymorphism. To explore this hypothesis, we performed a cross-sectional study to
evaluate the DNA methylation of 3 CpG sites using pyrosequencing within the ACE gene promoter of peripheral blood
leukocytes from 45 LBW children compared with 70 NBW children. Our results have revealed that LBW children have lower
methylation levels (P,0.001) in parallel with a higher ACE activity (P = 0.001). Adjusting for prematurity, gender, age, body
mass index, and family history of cardiovascular disease did not alter these findings. We have also performed analyses of
individual CpG sites. The frequency of DNA methylation was significantly different at two CpG sites (site 1: nucleotide
position +555; and site 3: nucleotide position +563). In addition, we have found a significant inverse correlation between
degree of DNA methylation and both ACE activity (P,0.001) and systolic blood pressure levels (P,0.001). We also observed
that the methylation level was significantly lower in LBW children who are carriers of the DD genotype compared to NBW
children with DD genotype (P,0.024). In conclusion, we are able to demonstrate that the hypomethylation in the 3 CpG
sites of ACE gene promoter is associated with LBW in 6 to 12 year-old children. The magnitude of these epigenetic changes
appears to be clinically important, which is supported by the observation that discrete changes in DNA methylation can
affect systolic blood pressure and ACE protein activity levels.
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Introduction
Epigenetic programming refers to alterations in gene expression
which are not explained by changes in the DNA sequence itself.
The mechanisms involved in these modifications comprise several
levels of gene regulation, which include DNA methylation, histone
modifications and RNA-based mechanisms [1,3]. It has been
suggested that epigenetic programming is susceptible to a number
of insults that occur in utero, leading to long-term changes in
phenotype [4–6].
The role of DNA methylation has been studied recently in
experimental models of fetal programming, suggesting that
epigenetic aspects are an important link between the intrauterine
environment and the risk for developing chronic diseases in later
life [7–12]. It is known that DNA methylation is largely established
during fetal or early postnatal life. DNA methylation is the most
stable epigenetic mark that influences the maintenance of genome
integrity, silencing of imprinted genes, X chromosome inactivation
and gene expression [1–6]. DNA methylation occurs primarily at
cytosines in cytosine-guanine dinucleotides (CpG) [13,14]. About
80% of CpG dinucleotides in mammalian genomes are methyl-
ated. On the other hand, there are regions of DNA sequence that
are very rich in CpG dinucleotides, termed CpG islands which
primarily occur in gene promoter regions. It is known that during
active gene transcription the CpG islands are unmethylated. An
interesting characteristic of many genes (,60%) is that they have a
CpG island at the 59 end of the promoter region which is
important for transcriptional regulation [13,14].
The angiotensin-converting enzyme (ACE), a member of the
renin-angiotensin system (RAS) has been investigated extensively
as a key gene for cardiovascular disease (CVD) [15–18]. The ACE
gene has been cloned and found to be characterized in humans by
a major polymorphism consisting of the insertion (I) or deletion (D)
of a 287-bp sequence within intron 16. It has been demonstrated
that the D allele and the DD genotype are associated with elevated
levels of ACE and a higher risk of adverse cardiovascular events
and end-organ damage [15,16,18]. A recent study from our group
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proposed an involvement of ACE insertion/deletion (I/D)
polymorphisms in the mechanisms of fetal programming of
hypertension [19]. We have shown that low birth weight (LBW)
children had a higher D allele frequency than normal birth weight
(NBW) children. When analyzed by quartiles of SBP or ACE
activity, we found a greater frequency of LBW children who were
carrying the DD genotype in the highest quartiles of these
parameters, whereas the NBW children tended to be in the lowest
quartile. It is intriguing that the ACE I/D polymorphism is
responsible for 40%–50% of the ACE serum concentration
variation, the remaining half could be determined by epigenetic
patterns [20]. It is acknowledged that the promoter region of the
ACE gene is characterized by a large number of CpG sites [21].
An alternative approach to understanding these ACE-related
alterations could be to assess the methylation status in the gene
promoter region.
In this context, fetal programming appears to involve epigenetic
modifications in response to alterations of the intrauterine
environment. These modifications are laid down largely during
early development and remain relatively fixed over a lifetime
[4,6,7]. Thus, it is conceivable that the epigenetic modification of
the ACE gene might show different interactions between birth
weight, blood pressure levels, plasma ACE activity and ACE I/D
polymorphism.
Although it is known that ACE may be detected in plasma, the
major part of ACE exists on the vascular endothelium, in non-
endothelial parenchymal cells, and on circulating leukocytes [22].
It has been reported that ACE expression on peripheral blood
mononuclear cells may contribute to local RAS activation and to
subsequent progression of the CVD [22]. Given this, we
investigated DNA methylation in the regulatory region of the
ACE gene in peripheral blood leukocyte of 115 children with both
normal birth weight and low birth weight.
Methods
The children we studied are a subsample of one cohort from a
recently published cross-sectional study by Ajala et al. [19]. Briefly,
a total of 167 children were selected (83 girls and 84 boys). Among
these children, 60 (31 girls and 29 boys) were identified as born
with a low birth weight (LBW children: BW#2.5 Kg), and 107 (52
girls and 55 boys) with a normal birth weight (NBW children:
BW$3.0 Kg) [17]. To carry out this study, we excluded 52
children (LBW: 15 and NBW: 37) because of inadequate amounts
of blood samples or DNA for evaluation of the ACE gene
promoter methylation. One hundred and fifteen children, aged
from 6 to 12, remained eligible for this study. Medical history was
taken and physical examination was performed in order to exclude
severe medical disorders. No child had any clinical signs of
hypertension, endocrinopathy, renal disease or chronic illness.
After the children were fasted overnight, blood samples were
collected by venipuncture of a forearm vein under standardized
conditions. The birth weight (BW) or gestational age data were
derived from maternal recall and later were cross-checked with
records obtained from the hospitals where the children were born.
This study was approved by the Research Ethics Committee of the
Federal University of Sa˜o Paulo (UNIFESP), and written informed
consent was obtained from the parents of the children enrolled in
the study. The procedures followed were in accordance with our
institutional guidelines.
Clinical Variables
Height was measured to the nearest 0.1 cm with a stadiometer
and weight to the nearest 0.1 kg with a mechanical medical scale.
Abdominal circumference was measured using a flexible tape to
the nearest 0.5 cm midway between the lower rib and the top of
the iliac crest. Systolic (SBP) and diastolic (DBP) blood pressures
were measured by auscultation after the child had remained seated
for 10 min. Three measurements were made at 2-min intervals,
and the mean value was used in the analysis. The same nurse,
blinded to the clinical data, examined and evaluated all 115
children.
Plasma ACE Activity
For plasma ACE activity, heparin tubes were centrifuged and
the plasma samples were stored at 280uC until analysis. The
plasma ACE activity was measured using Hippuryl-histidine-
leucine (HHL) as a substrate by a fluorometric method [23].
Briefly, 10 ml plasma samples were incubated with 490 ml of assay
buffer containing 5 mM Hip-His-Leu in 0.4 M sodium borate
buffer and 0.9 M NaCl for 15 min at 37uC. The reaction was
stopped by the addition of 1.2 ml of 0.34 N NaOH. The product,
His-Leu, was measured fluorimetrically (365-nm excitation and
495-nm emission) after the addition of 100 ml of o-phthaldialde-
hyde (20 mg/ml) in methanol, which was followed 10 minutes
later by the addition of 200 ml 3 N HCl and centrifuged (800 g for
5 minutes) at room temperature. A standard curve of 0.5 to
20 nmol His-Leu/tube was prepared for each assay. Enzyme
activity is reported as nmol/mL/min. Assays were carried out
under conditions that provided constant velocity and constant
enzyme-specific activity. To correct for the intrinsic fluorescence of
the plasma, time zero blanks (T0) were prepared by reversing the
order of the addition of enzyme and NaOH. The T0 blanks could
be used because the relative fluorescence of plasma (without
substrate) or substrate (without plasma) was constant under the
conditions of the assay [23]. All assays were performed in triplicate
by the same researcher, who used a blind analysis technique.
DNA Isolation and Bisulfite Treatment
For DNA isolation, EDTA tubes were centrifuged and the
peripheral blood leukocyte (buffy coat) were extracted and stored
at 280uC until analysis. Isolation of genomic DNA was performed
using the QIAmp DNAMini kits (Qiagen, Hilden, Germany). The
integrity of the isolated DNA was checked on a 1% agarose gel.
Bisulfite treatment of up to 1 mg of DNA was performed using an
EZ DNA Gold Methylation kit (Zymo Research, U.S.A.)
according to the manufacturer’s instructions.
Methylation Analysis Using Pyrosequencing
Pyrosequencing analysis was carried out for 3 CpG sites in
intron 1 of the ACE promoter using a PyroMark Q24 System
(Qiagen, Hilden, Germany). We used the predesigned methylation
assay from Qiagen (Hilden, Germany). The 3 CpG sites chosen
are part of the CpG island that includes: the promoter region, the
59UTR, the first exon and the first intron defined in the UCSC
genome browser (Figure S1). Details of the predesigned methyl-
ation assay used, including primer sequences, are provided in
Table S1. After bisulfite conversion, genomic DNA (20 ng) was
amplified by real time-PCR (Rotor Gene Q, Qiagen, Hilden,
Germany). The PCR reactions were conducted using the Pyro-
Mark PCR kit (Qiagen, Hilden, Germany) according to the
manufacturer’s protocol. PCR conditions were: 95uC for 15 min,
followed by 45 cycles of 94uC for 30 s, 56uC for 30 s, 72uC for
30 s, and, finally, 72uC for 10 min. Pyrosequencing methylation
analyses were conducted using the PyroMark Q24 (Qiagen,
Hilden, Germany) according to the manufacturer’s protocol. The
level of methylation was analyzed using PyroMark Q24 2.0.6
Software (Qiagen, Hilden, Germany), which calculates the
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methylation percentage (mC/(mC+C)) for each CpG site, allowing
quantitative comparisons (mC is methylated cytosine, C is
unmethylated cytosine). The results were expressed by the sum
of the methylation percentage for each CpG site (nucleotide
positions +555, +561, +563) of each child. To compare the
methylation levels (%) among BW groups, we used the average of
the three CpG sites. To verify the accuracy of the analysis, each
run included a negative control without template and a control
DNA from the EpiTect PCR Control DNA Set (Qiagen, Hilden,
Germany) that had contained both bisulfite converted 100%
methylated as well as unmethylated DNA as positive control and
unconverted unmethylated DNA as a negative control.
Statistical Analysis
All continuous variables were examined for normality with the
Kolmogorov-Smirnov test. Categorical variables were compared
using the x2 test. Student’s t test was used to compare the mean
values of continuous variables between BW groups. Analysis of
covariance (ANCOVA) was used to compare the mean values of
ACE protein activity, blood pressure levels and DNA methylation
between BW groups, adjusting for prematurity, gender distribu-
tion, age, and family history of CVD. Mann–Whitney U test was
further calculated to analyze the differences in DNA methylation
between BW groups at a particular I/D genotype, while the
relationship between DNA methylation between I/D genotype
was assessed using Kruskal-Wallis test. Haploview software was
used to analyze the ACE I/D alleles and to determine their
Hardy-Weinberg (HW) equilibrium status. The values of contin-
uous variables are expressed as the mean 6 standard error of the
mean (SEM) or median value and the interquartile range (IQR).
Pearson’s correlation coefficients were used to investigate associ-
ations between variables, before and after adjusting for confound-
ing factors. Statistical tests were two-tailed, and the significance
level was set at P,0.05. Statistical analyses were conducted using
SPSS version 13.0.
Results
We investigated the DNA methylation of 3 CpG sites in the
gene promoter of the ACE in peripheral blood leukocyte from 70
NBW children (41 boys and 29 girls) and 45 LBW children (20
boys and 25 girls). There were no significant differences between
the birth weight groups regarding gender, age, or family history of
CVD (Table 1). No difference in weight, height or body mass
index (BMI) was found between the two groups of children. In
contrast to NBW children, abdominal circumference was greater
in LBW children (Table 1). Children with a history of LBW
showed higher blood pressure levels when compared with those
born with a normal weight; also, ACE protein activity levels were
significantly elevated in these children (Table 1).
We assessed the DNA methylation of 3 CpG sites (nucleotide
positions +555, +561, +563) using pyrosequencing within the ACE
gene promoter. In the LBW children, there was a decreased in
methylation levels (mean: 5.460.28% in average over all 3 CpG
sites) when compared to NBW children (mean: 6.860.19%).
Among the LBW children, 58% were below the 50th percentile for
DNA methylation in ACE gene promoter and 18% remained
below the 10th percentile. In contrast, among NBW children, 30%
were below the 50th percentile, and no child was below the 10th
percentile (P=0.025).
To extend our data, we performed analyses of individual CpG
sites. The frequency of DNA methylation was significantly
different at two CpG sites (site 1: nucleotide position +555; and
site 3: nucleotide position +563) (Figure 1). These results have also
revealed that LBW children have lower levels of DNA methylation
at CpG site 1 (P=0.001) and 3 (P=0.009) when they are
compared with NBW children. No significant difference at CpG
site 2 (nucleotide position +561) was observed (P=0.136).
It is known that potential confounding variables can contribute
to these alterations on blood pressure levels, ACE protein activity
levels and DNA methylation. For these reasons, we adjusted our
data by prematurity, gender, age, BMI, and family history of
CVD. In the ANCOVA model, the adjustment for these
confounding factors did not alter the results (Table 2). We carried
out correlation analyses to clarify the relationship between DNA
methylation in the ACE gene with blood pressure levels and ACE
protein activity. In the first model, we found that SBP and ACE
protein activity levels were inversely related to the percentage of
DNA methylation (Table 3). Model 2 indicated that this negative
relationship persists in the presence of some important confound-
ing factors–prematurity, gender, age and family history of CVD–
whereas the correlation coefficient between ACE protein activity
levels and DNA methylation improved (Table 3). In contrast, the
coefficient for SBP and ACE protein activity worsened their
significance in Model 3, when birth weight data were included in
the final model (Table 3).
We investigated the interaction of ACE I/D polymorphism on
DNA methylation levels. Among the children who were evaluated,
10 (0.09) were homozygous for the I allele (II) (three LBW children
and seven NBW children), 63 (0.54) were heterozygous (ID) (22
LBW children and 41 NBW children), and 42 (0.37) were
homozygous for the D allele (DD) (20 LBW children and 22 NBW
children). There were significant differences in the DNA
methylation among the DD, ID and II genotypes (P= 0.001;
Kruskal-Wallis test) (Figure 2). As shown in Figure 3, the
methylation level of the 3 CpGs sites in the ACE gene promoter
was significantly lower in LBW children who are carriers DD
genotype, with a median value of 4.5% (IQR: 2%–7%) compared
to 6% (IQR: 4%–8%, P = 0.024) in NBW children with DD
genotype. On the other hand, there were no significant differences
in the DNA methylation levels among BW groups in the ID (NBW
- median value 7% and IQR: 4%–11%; LBW - median value 6%
and IQR: 2%–8%, P=0.075) or II genotype (NBW-median value
8% and IQR: 5%–11%; LBW-median value 8% and IQR: 7%–
9%, P=1.000) (Figure 3A, B and C).
Discussion
This study has demonstrated that the DNA methylation status
in 3 CpG sites from the ACE gene promoter was decreased in
LBW children. Moreover, this hypomethylation occurs simulta-
neously with an increase in the ACE protein activity and high
blood pressure levels in these children. Our data further
demonstrate that SBP levels and ACE protein activity were
inversely correlated with the degree of DNA methylation.
Therefore, it seems probable that the epigenetic regulation of
ACE gene promoter by hypomethylation could be a mechanism
whereby this enzyme might contribute to the development of
chronic diseases related to fetal programming.
An extensive body of studies has shown that LBW is related to a
greater risk of cardiometabolic comorbities, such as hypertension,
insulin resistance, dyslipidemia and obesity [24–27]. The under-
lying mechanisms are still unclear, but genetic and epigenetic
factors associated with both fetal growth and increased risk of
cardiometabolic disease may be involved. It is known that RAS is
more activated in the neonatal period and has an important role in
fetal development and growth [28]. In addition, the hyperactivity
of this system has been implicated in the development of
ACE Gene Hypomethylation in LBW Children
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Table 1. Main Characteristics of the Study Population.
NBW Children
(n =70)
LBW Children
(n =45) P Values
Birth weight (g) 3392.9627.2 2292.3623.9 ,0.001
Prematurity
Yes (%) (0) (16) ,0.001
No (%) (100) (84)
Gender
Girls (%) (41) (56) 0.138
Boys (%) (59) (44)
Age (years) 8.860.19 9.360.26 0.193
Weight (kg) 31.260.79 33.861.19 0.077
Height (cm) 134.861.23 138.761.58 0.055
Abdominal circumference (cm) 58.460.68 61.761.15 0.016
BMI (kg/m2) 16.960.21 17.460.35 0.217
SBP (mmHg) 9460.85 10161.04 ,0.001
DBP (mmHg) 6660.75 6960.86 0.035
Family history of CVD
Yes (%) (12) (16) 0.683
No (%) (88) (84)
ACE activity (nmol/mL/min) 75.662.44 90.963.22 ,0.001
DNA methylation in ACE gene (%) 7.060.19 5.360.23 ,0.001
Values are expressed as mean 6 SEM. Data was analyzed using two-tailed Student’s t test. BMI, body mass index; CVD, Cardiovascular disease; SBP, systolic blood
pressure; DBP, diastolic blood pressure.
doi:10.1371/journal.pone.0106138.t001
Figure 1. Bar graphs represents mean DNA methylation at individual CpG sites within the ACE gene promoter in NBW and LBW
children. The error bars indicate the standard error of mean and statistical significance was calculated using two-tailed Student’s t Test. *P,0.05 NBW
children vs. LBW children.
doi:10.1371/journal.pone.0106138.g001
ACE Gene Hypomethylation in LBW Children
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hypertension and other cardiometabolic disorders [29–31].
Previous studies have revealed that LBW is associated with the
modification of some elements of the RAS. Miyawaki et al. [32]
showed that plasma angiotensin II (AII) levels in early postnatal life
were higher in LBW than in NBW infants. Another study has
shown that ACE protein activity was inversely correlated with BW
in 3 month of age children [33]. We have previously reported that
AII concentration and ACE protein activity were increased in
LBW children [19,34]. Moreover, we found that LBW children
have higher frequency of the ACE D allele. Our present findings
are not only consistent with these previous data but also extended
them. Here we are able to demonstrate that hypomethylation in 3
CpG sites of the ACE gene promoter is associated with LBW in 6
to 12 year-old children, even after adjustment for potential
confounders. In accordance with these findings, 58% of the LBW
children were below the 50th percentile for DNA methylation in
the ACE gene promoter and 18% remained below the 10th
percentile. The magnitude of this epigenetic modification appears
to be clinically important, which is supported by the observation
that a discrete change in DNA methylation correlates with both
SBP and ACE protein activity levels.
Epigenetic marks are an important mechanism by which
heritable changes in gene activity and expression occur without
alteration in the DNA sequence [2]. It is known that epigenetic
modifications, such as DNA methylation, can be determined
during fetal development and remain relatively fixed over a
lifetime and through generations [4,6]. In this context, the Hunger
Winter Families Study demonstrated that individuals whose
parents had been exposed to famine during the preconception
period had a reduction in the DNA methylation of insulin-like
growth factor -2 (IGF-2) gene in old age [35,36].
In human, the existence of CpG sites in the ACE gene
underscores the high susceptibility of this gene to methylation and
consecutive modulation of the ACE expression. DNA methylation
and histone acetylation have been shown to influence the
regulation of somatic ACE [21]. Rivie`re et al. [21] found that
the methylation status of two CpG sites (2562/2244 and 2
202/2216), along with the acetylation status of histones, strongly
influences the activity of the ACE gene promoter in driving
transcription in a cell type-specific manner [21]. In this respect, we
evaluated 3 CpG sites within a CpG island which includes the
promoter region, the 39UTR, the first exon and the first intron.
Although the three selected CpG sites are not located within the
two CpG sites regions (2562/2244 and 2202/2216) previously
defined as key promoter regions, they are located at the first intron
that is still a region defined as an expression regulation controlling
region. Moreover, these three CpG sites are not within the ALU
element region subjected to the I/D mutation. In the present
study, the analysis of the three CpG sites together indicated that
the average DNA methylation of the ACE gene promoter was
lower in LBW children when compared to NBW subjects.
Additionally, when analyzing separately, we found difference at
two CpG sites (site 1: nucleotide position +555; and site 3:
nucleotide position +563). These results also revealed that LBW
children had lower levels of DNA methylation at CpG sites 1 and
3, when they were compared to NBW children. It is noteworthy
that the mean methylation levels of three CpGs in the ACE gene
are inverse correlated with ACE protein activity and SBP levels.
Similar results have been found after adjustment for prematurity,
gender, age and family history of CVD. When birth weight was
included in the final model, the magnitude of these correlations
decreased, suggesting that the strength of the associations occurred
due to birth weight differences among children. It may be possible
that the hypomethylation observed in these two specific CpG sites,
within the ACE gene promoter, directly contributes to a higher
ACE protein activity and could predispose LBW children to
Table 2. Blood Pressure Levels, ACE Activity and DNA Methylation in ACE Gene in Adjusted Covariance Model for Prematurity,
gender, age, BMI and Family History of Cardiovascular Disease.
NBW Children
(n =70) LBW Children (n =45) P Values
SBP (mmHg) 94 (91.6 to 95.4) 101 (99.2 to 103.5) ,0.001
DBP (mmHg) 66 (64.2 to 66.9) 69 (67.5 to 71.0) 0.002
ACE activity (nmol/mL/min) 76.1 (71.0 to 81.2) 90.2 (83.7 to 96.6) 0.001
DNA methylation in ACE gene (%) 6.8 (6.4 to 7.2) 5.1 (4.7 to 5.8) ,0.001
Values are adjusted for prematurity, gender, age, BMI, and family history of CVD. All values are expressed as means (95% confidence interval). Data were analyzed using
ANCOVA. SBP, systolic blood pressure; DBP, diastolic blood pressure.
doi:10.1371/journal.pone.0106138.t002
Table 3. Linear Correlation between of DNA Methylation in ACE Gene with ACE Activity and Blood Pressure Levels.
DNA Methylation in ACE Gene
Model 1 Model 2 Model 3
r P Value r P Value r P Value
ACE activity (nmol/mL/min) –0.430 ,0.001 –0.442 ,0.001 –0.362 ,0.001
SBP (mmHg) –0.354 ,0.001 –0.345 ,0.001 –0.206 0.031
DBP (mmHg) –0.129 0.168 –0.149 ,0.109 –0.071 0.462
Data were analyzed using Pearson’s correlation coefficients. SBP, systolic blood pressure; DBP, diastolic blood pressure. Model 1: no adjustment (crude model); Model 2:
adjustment by prematurity, gender, age and family history of CVD and; Model 3: adjustment by birth weight, prematurity, gender, age and family history of CVD.
doi:10.1371/journal.pone.0106138.t003
ACE Gene Hypomethylation in LBW Children
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undesirable outcomes later in life, such as elevated SBP levels
observed in these children.
Additional molecular mechanisms related to the ACE gene
should also be considered. If changes in the DNA methylation
levels of three CpGs in the ACE gene can promote higher ACE
protein activity, interactions with functional ACE I/D polymor-
phism can also have a part to play. A recent study from our group
investigated possible interactions between the ACE I/D polymor-
phism and birth weight as well as their effects on RAS components
and blood pressure levels in healthy children. We concluded that
there was a positive trend connecting the DD genotype with both
high ACE protein activity and SBP levels in LBW children [19]. In
the present study, the presence of homozygous DD genotype
resulted in a decrease of DNA methylation in LBW children.
Under this context, there is a possible interaction between ACE I/
D polymorphism and DNA methylation of three CpGs sites in the
ACE gene promoter in LBW children. We have to consider that
without prior knowledge of the potential role of this interaction, it
is extremely difficult to prove that it is present for a given LBW
phenotype. The demonstration of synergistic or interactive effects
from the epigenetic regulation of the ACE gene and I/D
polymorphism, would not only strongly reinforce the likelihood
of their pathophysiological involvement, but also help us to
understand the complexity of the genetic architecture.
We are aware that our conclusions are limited. The cross-
sectional nature of the study limits our possibilities of empirically
examining the extent and direction of causality between birth
weight, DNA methylation of the ACE gene promoter and blood
pressure levels. Another methodological consideration was the use
of the customized assay which evaluated only 3 CpG sites, which
does not include the CpG regions described by Rivie`re et al. [21].
Finally, our data are representative of a small population (e.g.
LBW children versus NBW children) and, thus, cannot be
generalized to different populations and contexts. Indeed, we
should keep in mind that epigenetic patterns will not only be
population-specific, but also cell-, tissue-, and time-specific.
In conclusion, we were able to demonstrate hypomethylation in
the 3 CpG sites of ACE gene promoter in 6 to 12 year-old LBW
children. The magnitude of these epigenetic changes appears to be
clinically important, which is supported by the observation that
discrete changes in DNA methylation can correlate with systolic
blood pressure and ACE protein activity levels. Moreover, the
presence of D alleles resulted in a decrease of DNA methylation,
suggesting an interaction between epigenetic regulation of the
Figure 2. Box plot of median DNA methylation of 3 CpG sites within the ACE gene promoter among ACE I/D genotypes, displayed
with the scatter plot of raw data. The inside each box represents the median, and the lower and upper edges of the boxes represents the 25th
and 75th percentiles, respectively, and upper and lower lines outside the boxes represent minimum and maximum values (error bars). The differences
of DNA methylation among ACE I/D genotypes is statistically significant (P= 0.001; Kruskal-Wallis Test).
doi:10.1371/journal.pone.0106138.g002
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ACE gene and I/D polymorphism in our cohort. Large
prospective studies are needed to definitively determine the
relevance of this epigenetic mechanism on the control of ACE
protein activity and blood pressure levels in LBW children.
Supporting Information
Figure S1 Schematic representation shows the analyzed
CpG sites relative to the ACE promoter region. Genomic
organization of the promoter region consisting of 6 exons (blue boxes),
introns (black lines) and the locations of amplicon (red box) evaluated
in this study by pyrosequencing. The 3 CpG sites chosen are part of
the CpG island that includes: the promoter region, the 59UTR, the
first exon and the first intron defined in the UCSC genome browser.
(http://genome.ucsc.edu/cgi-bin/hgTracks?db=hg19&position=
chr17%3A61554170-61555789&hgsid = 374432715_qhcffVWK3
dBfjwbK3jeR19g1yhCD).
(TIF)
Table S1 Assay Details for Pyrosequencing Analysis and
Primer Sequence.
(DOC)
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Figure 3. Box plot of median DNAmethylation of 3 CpG sites within the ACE gene promoter among BW groups stratified by ACE I/D
genotypes, displayed with the scatter plot of raw data. (A) Box plot demonstrates median DNA methylation in 42 children stratified by DD
genotype (P = 0.024; Mann–Whitney Test); (B) Box plot demonstrates median DNA methylation in 63 children stratified by ID genotype (P = 0.075;
Mann–Whitney Test); (C) Box plot demonstrates median DNA methylation in 10 children stratified by II genotype (P = 1.000; Mann–Whitney Test). The
inside each box represents the median, and the lower and upper edges of the boxes represents the 25th and 75th percentiles, respectively, and upper
and lower lines outside the boxes represent minimum and maximum values (error bars).
doi:10.1371/journal.pone.0106138.g003
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